Anti-tuberculosis drug resistance of Mycobacterium tuberculosis in the area of the Hospital de Sagunto from 1999 to 2004;Resistencias de Mycobacterium tuberculosis en el área del Hospital de Sagundo desde 1999 al 2004

Revista Clinica Espanola

Volumn 206, Issue 8, 2006, Pages 376-381

  Aragó Galindo, Miriam ^a,b   Belda Mira, A ^a   Contel, A Albert ^a   Serra Sanchis B ^a   Amoros Quiles I ^a   Prat Fornells, J ^a   Escoms Trullenque, R ^a   Gonzalez C ^a  

^a HOSPITAL DE SAGUNTO   (Spain)

^b NONE   (Spain)

Author keywords

Acquired drug resistance; Isoniazid; Mycobacterium tuberculosis; Primary drug resistance

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ALCOHOLISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG DISEASE; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLEURA EFFUSION; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; TUBERCULOSIS;

EID: 33749628484     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13090504     Document Type: Article

References (19)

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362:887-99.
2. Caminero Luna JA. Origen, presente y futuro, de las resistencias en tuberculosis. Arch Bronconeumol. 2001;37:35-42.
3. Smith KC, Armitige L, Wanger A. A review: reflections on the past, present and future of global epidemic disease. Expert Rev Anti Infect Ther. 2003;1(3):483-91.
4. Infuso A, Antoine D, Barboza P, Falzon D. Surveillance of anti-tuberculosis drug resistance in Europe, 1999. European comunicable disease bulletin. Eurosurveillance. 2002;7(6):93-100.
5. WHO/IUATLD) Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: third global report/the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1999-2002. (WHO/HTM/TB/2004.343).
6. Richard Long. Drug-resistant tuberculosis. CMAJ. 2000;163(4):425-8.
7. Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Bustreo F, Cohn DL, et al. Global Surveillance for antituberculosis-Drug resistance, 1994-1997. N Engl J Med. 1998;338:1641-9.
8. Marín Royo M, González Morán F, Moreno Muõz R, Pardo Serrano F, Prada Alfaro P, Arrendó Pena A, et al. Evolución de las resistencias a Mycobacterium tuberculosis en la provincia de Castellón. Años 1992-1998. Arch Bronconeumol. 2000;36:551-6.
9. Martín-Casabona N, Alcalde F, Coll P, González J, Manterota JM, Salvadó M, et al. Farmacorrestencia de Mycobacterium tuberculosis. Estudio multiocéntrico, en el área de Barcelona. Med Clin (Barc). 2000;115:493-8.
10. Dorronsoro I, Ojer M, Ruiz A, Navascués A, Gastesi C, Salicio Y. Estudio de la resistencia de Mycobacterium tuberculosis a los principales tuberculostáticos (Hospital de Navarra 1996-2003). An Sist Sanit Navar. 2005;28(1):29-34.
11. Centers for Disease Control and Prevention. Treatment of Tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR. 2003;52(RR-11):1-77.
12. Caminero Luna JA. Comentarios a la reciente normativa de tratamiento de la tuberculosis de la ATS/CDC/IDS. Arch Bronconeumol. 2003; 39(9):379-81.
13. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Sang Jae Kim, Reinero A, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med. 2001;344:1294-303.
14. Khan K, Muenning P, Behta M, Graff Zivin J. Global Drug-Resistance Patterns and the Management of Latent Tuberculosis Infection in Immigrants to the United States. N Engl J Med. 2002;347:1850-9.
15. Praharaj AK, Kalghatgi AT, Varghese SJ, Nagendra A. Incidence and Drug Susceptibility pattern of Mycobacterium tuberculosis in HIV infected Patientes. MJAFI. 2004;60:134-6.
16. Pereira M, Tripathy S, Inamdar V, Ramesh K, Bhavsar M, Date A, et al. Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res. 2005; 121:235-9.
17. Wosornu D, MacIntyre D, Watt B. An outbreak of isoniazid resistant tuberculosis in Glasgow 1981-1988. Respir Med. 1990;84(5):361-4.
18. Bondin SV. Quantitative and qualitative characteristics of bacterial excretion in socially maldapted patients with pulmonary tuberculosis and outcomes of the process. Probl Tuberk. 1992;(3-4):51-3.
19. Kim Hyo-Cheol, Goo Jim Mo, Hyum Ju, Park Seong Ho, Park Chang Min, Kim Tae Jung, et al. Multidrug-Resistant Tuberculosis Versus Drug-Sensitive Tuberculosis in Human Immunodeficiency Virus negative patients: Computed Tomography Features. Journal of Computer Assisted Tomography. 2004;28(3):366-71.